Amdocs (NASDAQ:DOX) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a research note issued on Wednesday.
Several other equities research analysts have also recently weighed in on DOX. Jefferies Group upgraded shares of Amdocs from a “hold” rating to a “buy” rating and lowered their price objective for the company from $71.37 to $60.20 in a research report on Monday. Stifel Nicolaus raised their price objective on shares of Amdocs from $72.00 to $75.00 and gave the company a “buy” rating in a research report on Wednesday, January 31st. Oppenheimer restated a “buy” rating and issued a $77.00 price objective on shares of Amdocs in a research report on Wednesday, January 31st. ValuEngine upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. Finally, Zacks Investment Research upgraded shares of Amdocs from a “sell” rating to a “hold” rating in a research report on Tuesday, January 16th. Five analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Amdocs has an average rating of “Hold” and an average target price of $69.31.
DOX stock opened at $66.97 on Wednesday. Amdocs has a 1-year low of $60.30 and a 1-year high of $71.72. The stock has a market cap of $9,883.28, a PE ratio of 21.60, a P/E/G ratio of 2.34 and a beta of 0.55.
Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, January 30th. The technology company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.17. Amdocs had a net margin of 11.72% and a return on equity of 15.13%. The firm had revenue of $977.70 million during the quarter, compared to the consensus estimate of $979.13 million. During the same period last year, the firm posted $0.90 EPS. The firm’s quarterly revenue was up 2.4% on a year-over-year basis. equities analysts anticipate that Amdocs will post 3.76 EPS for the current year.
A number of institutional investors and hedge funds have recently bought and sold shares of DOX. Delpha Capital Management LLC acquired a new stake in shares of Amdocs during the 4th quarter worth approximately $109,000. Focused Wealth Management Inc acquired a new stake in shares of Amdocs during the 4th quarter worth approximately $157,000. American International Group Inc. acquired a new stake in shares of Amdocs during the 4th quarter worth approximately $199,000. CENTRAL TRUST Co grew its position in shares of Amdocs by 45.0% during the 4th quarter. CENTRAL TRUST Co now owns 3,388 shares of the technology company’s stock worth $222,000 after buying an additional 1,052 shares during the period. Finally, Cerebellum GP LLC acquired a new stake in shares of Amdocs during the 4th quarter worth approximately $246,000. Hedge funds and other institutional investors own 93.46% of the company’s stock.
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.